Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata-Reference-Cited by-同舟云学术

Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata

Published:2022-02 Issue: Volume:Volume 16 Page:363-374
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Ramírez-Marín Hassiel Aurelio^ORCID,Tosti Antonella

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference61 articles.

1. Epidemiology and burden of alopecia areata: a systematic review

2. Alopecia areata

3. Prevalence of Alopecia Areata in the First National Health and Nutrition Examination Survey

4. National Alopecia Areata Foundation. What you need to know about alopecia areata; 2021. Available from: https://www.naaf.org/alopecia-areata. Accessed November 5, 2021.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects;European Journal of Medicinal Chemistry;2024-10

2. Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

3. Biological Evaluations and Computer-Aided Approaches of Janus Kinases 2 and 3 Inhibitors for Cancer Treatment: A Review;Pharmaceutics;2024-09-04

4. The mechanism of action and chemical synthesis of FDA newly approved drug molecules;Drug Development Research;2024-09

5. A review of TEC family kinases and their inhibitors in the treatment of alopecia areata;Archives of Dermatological Research;2024-07-30